Genetic epistasis of IL23/IL17 pathway genes in Crohn's disease

Background: The IL23/IL17 pathway is pivotal in the development of chronic mucosal inflammation seen in Crohn's disease (CD). Genetic variants in the IL23R and IL12B have been associated with CD susceptibility. We investigated 10 genes within the IL23/IL17 pathway in a case‐control study of 763 CD cases and 254 healthy controls. Methods: We identified a novel association in haplotypes in IL17A (empirical P = 0.02), IL17RA (P = 0.001), IL17RD (P = 0.001), IL12RB1 (P = 0.003), and IL12RB2 (P = 0.001) as well as confirming the association with IL12B variants (P = 0.003). Results: The cumulative risk for carrying an increased number of CD risk haplotypes from genes in this pathway rises to an odds ratio of 4.3 for carrying 5 risk haplotypes. We have previously demonstrated an association between this cohort and IL23R haplotypes. Pairwise analyses suggest that there is statistical interaction between variants in IL17A and IL23R (P = 0.047) and between variants in IL17RA and IL23R (P = 0.036). Furthermore, a significant association between CD and the widely replicated IL23R variants is only seen in the presence of IL17A or IL17RA variants. Conclusions: These data support the investigation of pathways implicated in CD pathogenesis in order to identify further susceptibility genes and also suggest that important gene–gene interaction is present in CD susceptibility.

[1]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[2]  C Rouquette,et al.  [Epidemiologic research]. , 1970, Bulletin de l'Institut national de la sante et de la recherche medicale.

[3]  T. Merriman,et al.  IL23R R381Q and ATG16L1 T300A Are Strongly Associated With Crohn's Disease in a Study of New Zealand Caucasians With Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.

[4]  S. Targan,et al.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. , 1993, Gut.

[5]  J. Rotter,et al.  Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. , 1989, Gastroenterology.

[6]  A. Tuulio-Henriksson,et al.  Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1. , 2007, Human molecular genetics.

[7]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[8]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[9]  R. D. Hatton,et al.  Transforming growth factor-beta induces development of the T(H)17 lineage. , 2006, Nature.

[10]  C. A. Thomas,et al.  Molecular cloning. , 1977, Advances in pathobiology.

[11]  R. D. Hatton,et al.  IL-17 family cytokines and the expanding diversity of effector T cell lineages. , 2007, Annual review of immunology.

[12]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[13]  Judy H. Cho,et al.  Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.

[14]  S. Targan,et al.  TNFSF15 is an ethnic‐specific IBD gene , 2007, Inflammatory bowel diseases.

[15]  J. R. Landis,et al.  A general overview of Mantel-Haenszel methods: applications and recent developments. , 1988, Annual review of public health.

[16]  S. Kugathasan,et al.  CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population , 2008, Inflammatory bowel diseases.

[17]  S. Targan,et al.  IL23R haplotypes provide a large population attributable risk for Crohn's disease , 2008, Inflammatory bowel diseases.

[18]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[19]  K. Gunderson,et al.  High-throughput SNP genotyping on universal bead arrays. , 2005, Mutation research.

[20]  D. D. de Jong,et al.  Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn’s disease but also ulcerative colitis , 2007, Alimentary pharmacology & therapeutics.

[21]  S. Targan,et al.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. , 2003, American journal of human genetics.

[22]  Wolfram Klein,et al.  rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants , 2007, PloS one.

[23]  Iwona Wrobel,et al.  IL‐23 receptor (IL‐23R) gene protects against pediatric Crohn's disease , 2007, Inflammatory bowel diseases.

[24]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[25]  Jonathan L Haines,et al.  Genetics, statistics and human disease: analytical retooling for complexity. , 2004, Trends in genetics : TIG.

[26]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[27]  Gudmundur A. Thorisson,et al.  The International HapMap Project Web site. , 2005, Genome research.

[28]  A. Andoh,et al.  Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.